The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLA.L Regulatory News (SLA)

  • There is currently no data for SLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

17 Jul 2019 09:19

RNS Number : 8204F
Standard Life Aberdeen plc
17 July 2019
 

Standard Life Aberdeen plc

 

Directorate change

 

The Board of Standard Life Aberdeen plc ('SLA') announces that Jonathan Asquith will be appointed as a Non-Executive Director with effect from 1 September 2019.

 

Jonathan Asquith brings a wealth of financial sector experience in both executive and non-executive directorship roles. In his executive career Jonathan worked at Morgan Grenfell for 18 years, rising to become Group Finance Director of Morgan Grenfell Group plc, before going on to take on the CFO roles at Deutsche Morgan Grenfell and subsequently Schroders plc. He also held leadership positions in Derivatives, Fixed Income, Equities and Private Banking. As a non-executive director, Jonathan has considerable relevant experience within the investment management and wealth industry having served, inter alia, on the Boards of Ashmore Group plc, Axa UK plc and Tilney Group Limited and as Chairman of Axa Investment Managers. He is currently Deputy Chairman of 3i Group plc, a position from which he is expected to retire next year.

 

Commenting on his appointment, Sir Douglas Flint, Chairman of SLA, said:

 

"I am very pleased to welcome Jonathan to our Board. His wide-ranging non-executive and executive experience across the financial services industry will bring further insight to our discussions".

 

On joining the Board, Jonathan will be appointed as the Senior Independent Director, a member and the Chair of the Remuneration Committee, and a member of the Nomination and Governance Committee.

 

Following this appointment, the Board will comprise four executive directors, six non-executive directors and the Chairman. The Board will be made up of four women and seven men. The Financial Conduct Authority and the Prudential Regulation Authority have been notified of this appointment and Jonathan's appointment as Chair of the Remuneration Committee is subject to regulatory approval. Jonathan's other appointments are listed below and no other information is required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

17 July 2019

Enquiries:

Media:

James Thorneley

 

+44 (0) 20 7463 6323

+44 (0) 7768 556 334

 

Institutional Equity Investors:

Jakub Rosochowski

 

+44 (0) 131 245 8028*

+44 (0) 7515 298 608

 

Group Secretariat:

Kenneth Gilmour

 

+44 (0) 131 372 1175

 

 

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

 

END

 

LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

 

Notes to Editors

 

Jonathan Asquith

 

Non-Executive Director's Fee

 

Jonathan's fee as a Non-Executive Director of SLA will be £73,500 per annum. His fee as Senior Independent Director will be £25,000. His fee as Chair of the Remuneration Committee will be £30,000 and his fee as a member of the Nomination and Governance Committee will be £10,000.

 

Interest in shares

 

As at the date of his appointment, Jonathan does not hold any shares in Standard Life Aberdeen plc.

 

Biographical details:

Nationality:

British

Education/Qualifications:

University of Cambridge, MA Law, (1978)

Inns of Court School of Law: Bar Finals (1979)

Other Non-Executive Appointments:

2018 - Present

 

2015 - Present

 

2011 - Present

Tilney Group Limited, Chair of Audit Committee

CiCap Limited (parent company of Coller Capital)

3i Group plc, Deputy Chairman and SID and Chair of Remuneration Committee

Previous Experience

Formerly Chairman of Citigroup Global Markets Limited, Citibank International plc, Dexion Capital plc and AXA Investment Managers. Non-executive director of Ashmore Group plc and Axa UK plc. 

 

Director of Schroders plc from 2002 to 2008, during which time he was Chief Financial Officer and later executive Vice Chairman. Previously in investment banking with Morgan Grenfell and Deutsche Bank.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGGUQGMUPBURM
Date   Source Headline
2nd Jul 202112:11 pmRNSForm 8.3 - UDG Healthcare plc
2nd Jul 202112:08 pmRNSForm 8.3 - Vectura Group plc
2nd Jul 202111:58 amRNSForm 8.3 - Sanne Group plc
2nd Jul 202111:49 amRNSForm 8.3 - Spire Healthcare Group plc
2nd Jul 202111:49 amRNSForm 8.3 - John Laing Group plc
2nd Jul 202111:44 amRNSForm 8.3 - Equiniti Group plc
2nd Jul 202111:42 amRNSForm 8.3 - Ultra Electronics Holdings plc
2nd Jul 202111:40 amRNSForm 8.3 - St. Modwen Properties plc
2nd Jul 202111:37 amRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 20211:06 pmRNSForm 8.3 - John Laing Group plc
1st Jul 20211:02 pmRNSForm 8.3 - Equiniti Group plc
1st Jul 202112:59 pmRNSForm 8.3 - Ultra Electronics Holdings plc
1st Jul 202112:55 pmRNSForm 8.3 - St. Modwen Properties plc
1st Jul 202112:50 pmRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 202112:36 pmRNSTotal Voting Rights
1st Jul 202111:45 amRNSForm 8.3 - UDG Healthcare PLC
1st Jul 202111:37 amRNSForm 8.3 - Vectura Group plc
1st Jul 202111:34 amRNSForm 8.3 - Sanne Group plc
1st Jul 202111:30 amRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 202111:53 amRNSForm 8.3 - John Laing Group plc
29th Jun 202111:51 amRNSForm 8.3 - Ultra Electronics Holdings plc
29th Jun 202111:46 amRNSForm 8.3 - St. Modwen Properties plc
29th Jun 202111:44 amRNSForm 8.3 - John Laing Group plc
29th Jun 20217:05 amRNSSale of shares in HDFC Life
28th Jun 20213:12 pmRNSForm 8.3 - Ultra Electronics Holdings plc
28th Jun 202110:47 amRNSForm 8.3 - John Laing Group plc
25th Jun 20214:24 pmRNSHolding(s) in Company
25th Jun 202111:50 amRNSForm 8.3 - John Laing Group plc
24th Jun 20215:16 pmRNSHolding(s) in Company
24th Jun 202111:19 amRNSForm 8.3 - John Laing Group plc
24th Jun 202110:19 amRNSHolding(s) in Company
23rd Jun 20212:38 pmRNSForm 8.3 - John Laing Group plc
22nd Jun 202111:55 amRNSForm 8.3 - Wm Morrison Supermarkets plc
21st Jun 20215:34 pmRNSHolding(s) in Company
21st Jun 202112:07 pmRNSForm 8.3 - UDG Healthcare PLC
21st Jun 202111:57 amRNSForm 8.3 - Vectura Group plc
21st Jun 202111:56 amRNSForm 8.3 - Sanne Group plc
21st Jun 202111:55 amRNSForm 8.3 - John Laing Group plc
21st Jun 202111:53 amRNSForm 8.3 - Spire Healthcare Group plc
21st Jun 202111:52 amRNSForm 8.3 - St. Modwen Properties plc
21st Jun 202111:51 amRNSForm 8.3 - Equiniti Group plc
18th Jun 20214:00 pmRNSHolding(s) in Company
18th Jun 202110:35 amRNSForm 8.3 - Sanne Group plc
17th Jun 20214:28 pmRNSHolding(s) in Company
17th Jun 202111:02 amRNSForm 8.3 - John Laing Group plc
17th Jun 202111:00 amRNSForm 8.3 - St. Modwen Properties plc
16th Jun 202112:37 pmRNSForm 8.3 - John Laing Group plc
16th Jun 202112:36 pmRNSForm 8.3 - Spire Healthcare Group plc
16th Jun 202112:34 pmRNSForm 8.3 - Senior plc
16th Jun 202110:20 amRNSForm 8.3 - UDG Healthcare PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.